Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2010
05/06/2010US20100113399 Salts and Polymorphs of a Tetracycline Compound
05/06/2010US20100113398 Treatment and/or Prevention of Non-Viral Epithelial Damage
05/06/2010US20100113397 Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity
05/06/2010US20100113396 Method and Composition for Potentiating an Opiate Analgesic
05/06/2010US20100113395 Low dosage forms of risedronate or its salts
05/06/2010US20100113394 Low dosage forms of risedronate or its salts
05/06/2010US20100113393 Boronic Acid Salts
05/06/2010US20100113392 Methods of using saha and bortezomib for treating multiple myeloma
05/06/2010US20100113391 Bicyclic heterocyclic compound
05/06/2010US20100113390 Oligosaccharides derived from fucoidan
05/06/2010US20100113389 Method of treating graft-rejection using dextran sulfate
05/06/2010US20100113388 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
05/06/2010US20100113387 Fatty acids for use as a medicament
05/06/2010US20100113386 N-benzyl substituted pyridyl porphyrin compounds and methods of use thereof
05/06/2010US20100113384 Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections
05/06/2010US20100113383 Bifidobacterial gene sequences and their use
05/06/2010US20100113382 Combined use of dipeptidyl peptidase 4 inhibitor and sweetener
05/06/2010US20100113381 Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds
05/06/2010US20100113380 P2x7 antagonists to treat affective disorders
05/06/2010US20100113379 cAMP DEPENDENT INDUCTION OF AUTOPHAGY
05/06/2010US20100113378 Compositions and Methods for Treating and Preventing Cancer Using Analogs of Vitamin D
05/06/2010US20100113377 Method of Treatment Using Alpha-1-Adrenergic Agonist Compounds
05/06/2010US20100113376 Process for dosing self-emulsifying drug delivery systems
05/06/2010US20100113375 Methods and related compositions using specific flavonoids and indanes to reduce weight and inhibit lipase, alpha-amylase and alpha-glucosidase activity in mammals
05/06/2010US20100113374 Methods and related compositions using specific flavonoids and indanes to reduce weight and inhibit lipase, alpha-amylase and alpha-glucosidase activity in mammals
05/06/2010US20100113373 Antiviral supplement formulations
05/06/2010US20100113372 Method For Preparing Kaempferol-3-0-Rutinoside and Composition of Skin External Application Comprising Thereof
05/06/2010US20100113371 Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds
05/06/2010US20100113370 Methods and compounds for modulating inflammatory processes
05/06/2010US20100113369 Means for preventing and treating cellular death and their biological applications
05/06/2010US20100113359 Dimethylphenoxy modulators of viral protease activity and/or parasitic enzyme activity
05/06/2010US20100113352 Retinol formulations and methods for their use
05/06/2010US20100113351 Therapeuting Compositions Comprising an RNAi Agent and a Neurotrophic Factor and Methods of Use Thereof
05/06/2010US20100113344 Method Of Detection Of Nucleic Acids With A Specific Sequence Composition
05/06/2010US20100113343 Methods involving lef-1 regulation and use of lef-1 or compounds altering lef-1 signalling for treating or preventing diseases
05/06/2010US20100113340 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof
05/06/2010US20100113334 Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility
05/06/2010US20100113332 Method of treating an inflammatory disease by double stranded ribonucleic acid
05/06/2010US20100113331 Substituted Imidazole Derivatives, Compositions, and Methods of Use as PtPase Inhibitors
05/06/2010US20100113330 Tetrahydropyrido[4,3-d]pyrimidinone derivatives and methods of use thereof
05/06/2010US20100113305 Oxazole and thiazole combinatorial libraries
05/06/2010US20100112685 Thymidine Kinase Mutants and Fusion Proteins Having Thymidine Kinase and Guanylate Kinase Activities
05/06/2010US20100112162 25-Hydroxy vitamin D3 compositions
05/06/2010US20100112105 Antimicrobial efficacy of aframomum Melegueta extract against propionibacterium acnes
05/06/2010US20100112104 Cosmetic preparations designed to reduce unsightly cellulite
05/06/2010US20100112103 Burn treatment composition and method
05/06/2010US20100112098 Effects of a decaffeinated green coffee extract on body weight control by regulation of glucose metabolism
05/06/2010US20100112093 Compositions and methods for therapeutic delivery with frozen particles
05/06/2010US20100112091 Use of ramoplanin to treat diseases associated with the use of antibiotics
05/06/2010US20100112090 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
05/06/2010US20100112088 Materials and methods for treatment of disorders associated with oxidative stress
05/06/2010US20100112083 Pharmaceutical product for modulating bone formation, process for modulating bone formation
05/06/2010US20100112079 Thyroid Hormone Analogs and Methods of Use
05/06/2010US20100112076 Gellan-Gum Nanoparticles and Methods of Making and Using the Same
05/06/2010US20100112075 Compositions of microparticles and granules for oral controlled release of substances for veterinary use
05/06/2010US20100112070 Composition and dosage form comprising a particle formulation and suspending vehicle
05/06/2010US20100112066 Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent
05/06/2010US20100112065 Therapeutic ultrasound gel
05/06/2010US20100112064 Transdermal therapeutic system comprising ion pair microreservoirs
05/06/2010US20100112063 Method for preparing a hydrogel adhesive having extended gelation time and decreased degradation time
05/06/2010US20100112061 Monophosphates as Mutual Prodrugs of Muscarinic Receptor Antagonists and Beta-Agonists for the Treatment of COPD And Chronic Bronchitis
05/06/2010US20100112056 Immediate release dosage forms of sodium oxybate
05/06/2010US20100112054 Tablets and discs with compartments with two or more drugs for release at certain intervals and with specific rates
05/06/2010US20100112053 Gastric retention-type sustained-release levodopa preparation
05/06/2010US20100112052 Osmotic tablet with a compressed outer coating
05/06/2010US20100112051 Tianeptine sulfate salt forms and methods of making and using the same
05/06/2010US20100112050 Dosage Form For Insertion Into The Mouth
05/06/2010US20100112049 improved bioavailabilty; micronized fenofibrate, a surfactant and a binding cellulose derivative as a solubilization adjuvant
05/06/2010US20100112048 Dosage Regimen and Medicament For Reducing Risk of Onset or Progression of Dementia by Administration of Specific Vitamins and Nsaid
05/06/2010US20100112047 Omega 3 fatty acid formulations
05/06/2010US20100112046 Formulations of suberoylanilide hydroxamic acid and methods for producing same
05/06/2010US20100112045 Surface-treated modafinil particles
05/06/2010US20100112044 Method and apparatus for encapsulating pharmaceutical and nutriceutical bioactives for intestinal delivery
05/06/2010US20100112042 Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics
05/06/2010US20100112041 Endoxifen Compositions And Methods
05/06/2010US20100112039 Lornafarnib in combination with a taxane selected from paclitaxel and docetaxel, and also carboplatin, cisplatin or oxaliplatin
05/06/2010US20100112038 Methods of treating neurological conditions with hematopoeitic growth factors
05/06/2010US20100112037 S1p receptor agonists for the treatment of cerebral malaria
05/06/2010US20100112036 Cyanoacrylate-based liquid microbial sealant drape
05/06/2010US20100112035 Multiple component food product useful for delivering glucosamine and/or n-acetyl-d-glucosamine
05/06/2010US20100112030 Role of hedgehog signaling in atherosclerosis and cardiovascular disease
05/06/2010US20100112027 Penis Enlargement
05/06/2010US20100112023 Silicone microparticles comprising silicone elastomer spherical microparticles coated with polyorganosilsesquioxane, and method of producing same
05/06/2010US20100112016 Ophthalmic oil-in-water emulsions containing prostaglandins
05/06/2010US20100112014 Novel hydrogel compositions and methods of using
05/06/2010US20100112013 Adjuvant comprising oligonucleotide and non-toxic lipopolysaccharide
05/06/2010US20100112012 Modulation of immune responses
05/06/2010US20100111998 Hiv vaccines based on env of multiple clades of hiv
05/06/2010US20100111993 Recombinant vaccines and use thereof
05/06/2010US20100111990 Polypeptide Recognized by Anti HIV-1 GP41 Antibodies Isolated from Highly HIV-1 Exposed, Non Infected Women
05/06/2010US20100111988 Small peptide for anti-angiogenesis and use thereof
05/06/2010US20100111981 Synthetic monodisperse hemozoin crystals preparation and uses thereof
05/06/2010US20100111972 Method for preventing or treating opiate tolerance and dependence
05/06/2010US20100111968 Methods for Mediating Fibrotic Response
05/06/2010US20100111965 Combination therapy
05/06/2010US20100111955 Hedgehog signaling pathway proteins and uses thereof
05/06/2010US20100111944 Method of diagnosing, classifying and treating endometrial cancer and precancer
05/06/2010US20100111943 Compositions and methods for inhibiting cancer metastasis
05/06/2010US20100111942 Combination therapy for the treatment of ocular neovascular disorders
05/06/2010US20100111930 Methods and Compositions for Detecting Receptor Ligand Mimetics
1 ... 2281 2282 2283 2284 2285 2286 2287 2288 2289 2290 2291 2292 2293 2294 2295 2296 2297 2298 2299 2300 2301 ... 7860